Eyepoint Pharmaceuticals (NASDAQ:EYPT) reported topline results from LUGANO, the first of two Phase III trials evaluating ...
The attacks began on a July weekend and have continued for a month, stretching from Moscow and St. Petersburg, to cities in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results